Phase II randomized, double-blind, study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients hcrn GI14-198

Authors

• S J. Cohen

Publication/Presentation Date

1-2019

Volume

37

Issue

4

Published In/Presented At

DOI: 10.1200/JCO.2019.37.4_suppl.TPS475

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article